Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients
Clinical trial NCT04555486 · COMPLETED
Trial details
- NCT number
- NCT04555486
- Sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2021-09-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.